Der foreligger ingen oplysninger om maternel- føtal transmission af hepatitis B- virus hos gravide kvinder i behandling med lamivudin.
There is no information available on maternal-foetal transmission of hepatitis B virus in pregnant women receiving treatment with lamivudine.